K981801

Substantially Equivalent

ACCUSIGN TCA, BIOSIGN TCA, STAUS DS TCA

Applicant: Princeton BioMeditech Corp.
Product code: LFH
Advisory panel: Clinical Toxicology
Date received: 1998-05-21
Decision date: 1998-08-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Princeton, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.